Effect Comparative Study of Rosuvastatin and Atorvastatin in Treatment of Coronary Heart Disease
Objective To explore the effect and safety of rosuvastatin and atorvastatin in treatment of coronary heart disease respectively. Methods The sample subjects were 90 patients with coronary heart disease,with study period from January 2022 to April 2023. The patients were divided into two groups according to treatment sequence. Those received treatment first were defined as the control group,treated with atorvastatin treatment,and those receive treatment later were defined as the observation group,treated with rosuvastatin treatment. Curative effect,blood lipid indicators,and adverse reactions were compared between two groups. Results Total effective rate of the observation group reached 95.55％,which was higher than 80.00％ in the control group. The improvement effect of blood lipid indicators of triglycerides and total cholesterol in the observation group after treatment was better than the control group. Incidence of adverse reactions was 6.67％ in the observation group and 8.89％ in the control group. Conclusion Among treatment schemes for patients with coronary heart disease,compared with atorvastatin,rosuvastatin can achieve better significant effect,which can be first priority based on the condition of patients.
万方数据
维普
